☐ | Preliminary Proxy Statement |
☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
☒ | Definitive Proxy Statement |
☐ | Definitive Additional Materials |
☐ | Soliciting Material Pursuant to § 240.14a-12 |
(Name of Registrant as Specified in its Charter) | ||
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) | ||
☒ | No fee required. | ||||
☐ | Fee paid previously with preliminary materials. | ||||
☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. | ||||
• | The election of each of David Hopkinson and Thomas Looney, as Class III director nominees, each to serve until his term expires or until his successor is duly elected and qualified, as described herein; |
• | The ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending May 31, 2025; |
• | Approval to increase the number of shares of common stock the Company is authorized to issue from 1,208,000,000 shares of capital stock to 1,426,000,000 shares of capital stock (the “Authorized Shares Proposal”); |
• | Approval of the governance changes to the Company’s Fourth Amended and Restated Certificate of Incorporation (the “Charter”) to (i) declassify the Board and provide that all directors will be elected at each annual meeting of stockholders and (ii) eliminate the provision of the Charter that allows stockholders to remove directors only for cause (collectively, the “Governance Proposal”); and |
• | Any other business properly brought before the Annual Meeting. |
1. | to elect David Hopkinson and Thomas Looney as Class III director nominees, each to serve until his term expires or until his successor is duly elected and qualified, as described herein; |
2. | to ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending May 31, 2025; |
3. | to approve an increase in the number of shares of common stock the Company is authorized to issue from 1,208,000,000 shares of capital stock to 1,426,000,000 shares of capital stock (the “Authorized Shares Proposal”); |
4. | to approve the governance changes to the Company’s Fourth Amended and Restated Certificate of Incorporation (the “Charter”) to (i) declassify the Board and provide that all directors will be elected at each annual meeting of stockholders and (ii) eliminate the provision of the Charter that allows stockholders to remove directors only for cause (collectively, the “Governance Proposal”); and |
5. | to consider and act upon any other business that may properly come before the Annual Meeting or any adjournment or postponement of the Annual Meeting. |
Name | Current Position | Class | Term Expires | ||||||||
Jodi Butts | Nominating & Governance Committee Member; Independent Director | Class III | 2024 annual meeting of stockholders | ||||||||
David Clanachan | Audit Committee Member; Independent Director | Class II | 2026 annual meeting of stockholders | ||||||||
John M. Herhalt | Chair of the Audit Committee; Independent Director | Class I | 2025 annual meeting of stockholders | ||||||||
David Hopkinson | Nominating and Governance Committee & Compensation Committee Member; Independent Director | Class III | 2024 annual meeting of stockholders | ||||||||
Thomas Looney | Chair of the Compensation Committee and Audit Committee Member; Independent Director | Class III | 2024 annual meeting of stockholders | ||||||||
Renah Persofsky | Vice-Chair (Lead Director) and Chair of the Nominating and Governance Committee; Independent Director | Class II | 2026 annual meeting of stockholders | ||||||||
Irwin D. Simon | Chairman of the Board of Directors; President and Chief Executive Officer | Class II | 2026 annual meeting of stockholders | ||||||||
1 |
2 |
• | elect Mr. Hopkinson and Mr. Looney, the two (2) Class III director nominees, each to serve a term of three years expiring at the 2027 Annual Meeting of Stockholders, to our Board; |
• | ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending May 31, 2025; |
• | approve an increase the number of shares of common stock the Company is authorized to issue from 1,208,000,000 shares of capital stock to 1,426,000,000 shares of capital stock (the “Authorized Shares Proposal”); |
• | approve the governance changes to the Company’s Fourth Amended and Restated Certificate of Incorporation (the “Charter”) to (i) declassify the Board and provide that all directors will be elected at each annual meeting of stockholders and (ii) eliminate the provision of the Charter that allows stockholders to remove directors only for cause (collectively, the “Governance Proposal”); and |
• | consider and act upon any other business that may properly come before the Annual Meeting or any adjournment or postponement of the Annual Meeting. |
1. | FOR the election of the two (2) Class III director nominees; |
2. | FOR the ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending May 31, 2025; |
3. | FOR the approval of the Authorized Shares Proposal: |
4. | FOR the approval of the Governance Proposal. |
• | To vote by “virtually” attending the Annual Meeting, login to the link: www.virtualshareholdermeeting.com/TLRY2024, and follow the instructions provided. |
• | To vote using the enclosed proxy card, simply complete, sign and date the enclosed proxy card that may be delivered and return it promptly in the envelope provided. If you return your signed proxy card to us before the Annual Meeting, we will vote your shares as you direct. |
• | To vote through the internet, go to www.proxyvote.com to complete an electronic proxy card. You will be asked to provide the company number and control number from the enclosed proxy cards. Your internet vote must be received by 11:59 PM EST, on November 21, 2024 to be counted. |
3 |
4 |
Proposal | Votes Required | Voting Options | Impact of “Withhold” or “Abstain” Votes | Broker Discretionary Voting Allowed | ||||||||||
Proposal No. 1: Election of Directors | The plurality of the votes of shares of the voting power present or represented by proxy. This means that the two nominees receiving the highest number of affirmative “FOR” votes will be elected. | “FOR” “WITHHOLD” | None(1) | No(5) | ||||||||||
Proposal No. 2: Ratification of Appointment of Independent Registered Public Accounting Firm | The affirmative vote of the holders of a majority of shares of the voting power present or represented by proxy. | “FOR” “AGAINST” “ABSTAIN” | Will count as a vote “against”(3) | Yes(4) | ||||||||||
Proposal No. 3: Approval of the Authorized Shares Proposal | The affirmative vote of the holders of a majority of the shares of voting power casting votes in person (online during the virtual meeting) or by proxy at the Annual Meeting by the holders entitled to vote thereon. This means that the Authorized Shares Proposal will be approved if the votes cast “FOR” the proposal exceed the votes cast “AGAINST” the proposal. | “FOR” “AGAINST” “ABSTAIN” | None(5) | Yes(4) | ||||||||||
Proposal No. 4: Approval of Governance Proposal | The affirmative vote of the holders of 66 2/3% of the outstanding shares of our common stock entitled to vote generally at an election of directors. | “FOR” “AGAINST” “ABSTAIN” | Will count as a vote “against”(3) | No(2) | ||||||||||
(1) | Votes that are “withheld” will have the same effect as an abstention and will not count as a vote “FOR” or “AGAINST” a director, because directors are elected by plurality voting. |
(2) | As this proposal is not considered a discretionary matter, brokers lack authority to exercise their discretion to vote uninstructed shares on this proposal. Accordingly, when a beneficial owner of shares held in street name does not give voting instructions to his or her broker, bank or other agent as to how to vote on matters deemed to be “non-routine,” the broker, bank or other agent cannot vote the shares. These un-voted shares are counted as “broker non-votes” and will have the effect of a vote “against” the proposal. |
(3) | Abstentions and votes withheld will not be included in the numerator (since they are not affirmative votes) but will be included in the denominator (since they are shares “entitled to vote”). Therefore, abstentions and votes withheld will have the same effect as a vote “against” the proposal. |
(4) | As this proposal is considered a discretionary matter, brokers are permitted to exercise their discretion to vote uninstructed shares on this proposal. |
(5) | Abstentions, and in the case of the Election of Directors proposal, “broker non-votes” are not counted as votes cast and will have no effect on the vote on this proposal. |
5 |
• | mail a written notice “revoking” your earlier vote to Broadridge Financial Solutions, Inc. (Broadridge), 51 Mercedes Way, Edgewood, NY 11717; |
• | submit to Broadridge a properly completed and signed proxy card with a later date; |
• | vote again telephonically or electronically (available until 11:59 p.m. EST on November 20, 2024); or |
• | vote in person at the Annual Meeting; however, your virtual attendance at the Annual Meeting alone will not revoke your proxy. |
• | as necessary to meet applicable legal requirements; |
• | to allow for the tabulation and certification of votes; and |
• | to facilitate a successful proxy solicitation. |
6 |
7 |
8 |
David Hopkinson | Independent Director | ||||
Director Since: May 2021 Age: 53 Committees: Nominating and Governance Committee & Compensation Committee | Other Public Company Boards: Mr. Hopkinson is not a director of any other public company board. | ||||
Executive Highlights: | |||||
Mr. Hopkinson is an accomplished executive with more than 25 years of diverse sports and entertainment industry experience. Most recently Mr. Hopkinson served as the President and Chief Operating Officer at Madison Square Garden Sports Corp. (MSG Sports) from 2020 to 2024, where he was responsible for setting the business strategy and overseeing all aspects of business operations across MSG Sports’ portfolio of assets, which includes the New York Knicks (NBA) and New York Rangers (NHL). Prior to MSG Sports, he served as Global Head of Partnerships for Real Madrid Club de Futbol, one of the world’s top revenue-generating football clubs, where he was responsible for all aspects of global partnerships. Before joining Real Madrid in 2018, Mr. Hopkinson spent over 20 years with Maple Leaf Sports and Entertainment (MLSE) in roles of increasing responsibility. In his last role with the Company, Mr. Hopkinson served as Chief Commercial Officer, where he was responsible for all revenue generation across MLSE’s portfolio of teams, which includes the Toronto Maple Leafs (NHL), Toronto Raptors (NBA) and Toronto FC (MLS). Mr. Hopkinson has served on the Chancellor’s Advisory Committee at McGill University in Montreal, in addition to the Boards of Canada Basketball, Canada’s Walk of Fame, and Women’s College Hospital Foundation in Toronto. In 2013, he was awarded the Queen Elizabeth II Diamond Jubilee Medal in recognition of Service to Canada. | |||||
Select Skills and Qualifications: | |||||
Extensive operational, management and revenue generation experience. | |||||
Thomas Looney | Independent Director | ||||
Director Since: May 2021 Age: 61 Committees: Audit Committee & Chair of the Compensation Committee | Other Public Company Boards: Mr. Looney is not a director of any other public company board. | ||||
Executive Highlights: | |||||
Tom Looney is the former President of Diageo US Spirits & Canada. In this position Mr. Looney maintained full responsibility for the growth and development of the company’s spirits business in the United States & Canada including brands such as Smirnoff, Crown Royal, Baileys, Johnnie Walker, Captain Morgan, and Ketel One. Mr. Looney was also a member of Diageo’s North American Executive Team. Previously, Mr. Looney held the position of President, Diageo Beer Company overseeing US sales, finance, marketing, and innovation teams. | |||||
Select Skills and Qualifications: | |||||
Extensive innovation, sales, finance and marketing experience, especially in the beverage alcohol industry, and risk management. | |||||
9 |
Irwin D. Simon | Chairman, President, and Chief Executive Officer | |||||||
Director Since: May 2021 Age: 66 Committees: None | Other Public Company Boards: Mr. Simon is currently a director of Stagwell Inc. | |||||||
Executive Highlights: | ||||||||
Irwin D. Simon is a Canadian American businessman and visionary leader who serves as Chairman and Chief Executive Officer at Tilray Brands, Inc, the world’s leading lifestyle consumer packaged goods company with a diversified portfolio of consumer brands across medical and adult-use cannabis, wellness foods, and beverages including craft beer, spirits, and cannabis drinks. Tilray’s unprecedented platform operates in over 20 countries and leads across markets as the #1 medical and adult-use cannabis company in Canada, the largest federally legal cannabis market in the world, the leader in medical cannabis across Europe, and 5th largest craft brewer in the United States. Mr. Simon was until August 2024, the Executive Chairman of Whole Earth Brands, Inc., a global industry-leading platform focused on the “better for you” consumer packaged goods and ingredients space. Mr. Simon continues to serve as Lead Director at Stagwell Inc., a digital-first global marketing network that delivers scalable, seamless solutions through a unique combination of culture-moving creativity and leading-edge technology. | ||||||||
A transformative entrepreneur for over four decades, Mr. Simon is recognized as a forefather of the organic and natural products industry. In 1993, he founded and served as the Chairman and CEO of The Hain Celestial Group, Inc., a leading organic and natural products company, providing consumers with A Healthier Way of Life™. During his 25 year tenure, he grew Hain Celestial to a $3 billion business with operations in North America, Europe, Asia and the Middle East. | ||||||||
Mr. Simon also serves on the board of directors at Tulane University and the Board of Trustees at Poly Prep Country Day School. | ||||||||
Select Skills and Qualifications: | ||||||||
Executive and public company board leadership, entrepreneurship, extensive global consumer-packaged goods business and brand development experience, as well as in-depth knowledge of our industry. | ||||||||
10 |
Renah Persofsky | Independent Director | ||||
Director Since: May 2021 Age: 66 Committees: Vice-Chair (Lead Director) and Chair of the Nominating and Governance Committee, Independent Director | Other Public Company Boards: Ms. Persofsky is currently a director of Hydrofarm Holdings Group, Inc. and GreenLane Holdings. | ||||
Executive Highlights: | |||||
Renah Persofsky , ICD.D, Vice-Chair (Lead Director) and Chair of the Nominating and Governance Committee, Independent Director. With a remarkable career spanning over four decades, Renah Persofsky is a seasoned business leader and a trailblazer in various industries. Currently, she is the executive chairman of Green Gruff, a pioneering dog wellness company committed to producing organic and sustainable dog supplements and treats. In addition to her role at Green Gruff, Ms. Persofsky serves as a distinguished member of the board of Hydrofarm Holdings Group, America’s oldest and largest independent wholesaler and manufacturer of hydroponics equipment and grow lights. She also serves on the board of Oceansix, an Israeli founded forward-thinking technology and manufacturing company in the renewable plastic industry. Ms. Persofsky’s experience in the cannabis industry is further solidified through her role on the Board of Greenlane Holdings, one of the largest global sellers of cannabis accessories. Her extensive experience includes serving as an executive consultant to many brands, including Tim Hortons, Canadian Tire, CIBC, Canada Post, and Interac. She also held an executive officer position at the Bank of Montreal. Ms. Persofsky’s expertise in e-commerce is globally recognized. She has co-chaired the Canadian Minister’s Advisory Committee on Electronic Commerce and served as a special advisor to the Minister of Foreign Affairs and Trade. Her contributions to these roles underscore her commitment to innovation and her vision for a digitally connected world. | |||||
Select Skills and Qualifications: | |||||
Public company board experience, extensive governance and management experience. | |||||
David Clanachan | Independent Director | ||||
Director Since: May 2021 Age: 62 Committees: Audit Committee Member | Other Public Company Boards: Mr. Clanachan is not a director of any other public company board. | ||||
Executive Highlights: | |||||
David F. Clanachan is the current Chair of the Board of Directors for SteamWhistle brewery in Canada, while serving as a consultant to a number of food service companies throughout Canada. He was the past Commissioner of the Canadian Premier League, a post he held from 2018 until 2021. Mr. Clanachan was also the Chairman of Restaurant Brands International, Canada until 2018. He was named President and Chief Operating Officer of Tim Hortons from 2014 to 2018, and had more than 35 years of service for that brand. Mr. Clanachan holds a Bachelor of Commerce degree from the University of Windsor. Mr. Clanachan brings to the Board significant experience in consumer products and services, as well as financial, international growth, and general management experience. | |||||
Select Skills and Qualifications: | |||||
Extensive consumer products and services, financial, international growth, and general management experience. | |||||
11 |
John M. Herhalt | Independent Director | ||||
Director Since: May 2021 Age: 67 Committees: Chair of the Audit Committee | Other Public Company Boards: Mr. Herhalt is not a director of any other public company board. | ||||
Executive Highlights: | |||||
John M. Herhalt is a FCPA (FCA) and a retired partner from KPMG and has over 45 years of experience. He has worked across several industry sectors including automotive manufacturing, consumer products, infrastructure, power and utilities, and the public sector. During his time with KPMG, Mr. Herhalt served as Canada’s national advisory services business leader, national public sector leader, and KPMG International’s global head of infrastructure, government, and health care sectors providing subject matter advice and support to various KPMG member firms and their clients on a variety of projects in the Americas, Europe, Middle East, and Asia. After retiring from KPMG, Mr. Herhalt has continued to provide management consulting services on a part-time basis and serves as a director on several boards. | |||||
Select Skills and Qualifications: | |||||
Extensive accounting, financial, governance, risk management and information systems audits, and global business experience. | |||||
Jodi Butts | Independent Director | ||||
Director Since: May 2021 Age: 52 Committees: Nominating & Governance Committee Member | Other Public Company Boards: Ms. Butts is currently a director of Canada Goose Holdings Inc. | ||||
Executive Highlights: | |||||
Jodi Butts is a senior governance consultant at WATSON Advisors Inc., with more than 20 years’ experience in governance and law, working with public and private corporations, public sector entitles, member-based organizations, regulatory bodies, and not-for-profit organizations. Ms. Butts brings deep governance expertise gained from her experience as a lawyer, CEO, senior executive, and as a director of public, private, and not-for-profit corporations. Ms. Butts connects governance with people, strategy, and operations to bring a wealth of practical know-how to boards and executive teams. Ms. Butts currently serves as an independent director of Canada Goose Inc. and as chair of The Walrus Board of Directors. She also holds advisory roles with Bayshore Home Healthcare, and the Canadian Centre for the Purpose of the Corporation. Ms. Butts is a retired member of the University of Windsor Board of Governors. Previously, Ms. Butts served as CEO of Rise Asset Development, and Senior Vice-President Corporate Affairs and Operations for Mount Sinai Hospital. Ms. Butts holds a BA (English Literature and History) from the University of Windsor and a Bachelor of Laws from the University of Toronto where she also received her master’s degree in Canadian history. | |||||
Select Skills and Qualifications: | |||||
Executive and public company board experience, entrepreneurship, operations and extensive corporate governance experience, including with respect to environmental and social matters. | |||||
12 |
Irwin D. Simon | Renah Persofsky | Jodi Butts | David Clanachan | John M. Herhalt | David Hopkinson | Tom Looney | |||||||||||||||||
Knowledge, Skills & Experience | |||||||||||||||||||||||
Accounting / Financial Reporting | X | X | |||||||||||||||||||||
Business Operations | X | X | X | X | X | X | X | ||||||||||||||||
Corporate Governance | X | X | X | X | X | X | |||||||||||||||||
Environmental / Social /Governance | X | X | |||||||||||||||||||||
Financial Literacy / Expertise | X | X | X | X | X | ||||||||||||||||||
Government / Regulatory | X | X | X | ||||||||||||||||||||
Human Capital Management | X | ||||||||||||||||||||||
Independence | X | X | X | X | X | X | |||||||||||||||||
Consumer Packaged Goods | X | X | |||||||||||||||||||||
International Business (outside North America) | X | X | X | X | |||||||||||||||||||
Investor Relations Management | X | ||||||||||||||||||||||
Mergers & Acquisitions | X | X | X | X | X | ||||||||||||||||||
Public Company Executive Experience | X | X | X | X | X | X | X | ||||||||||||||||
Recent Public Company Board Experience | X | X | X | X | X | ||||||||||||||||||
Risk Management | X | X | X | X | X | ||||||||||||||||||
Technology / Cybersecurity | X | X | X | ||||||||||||||||||||
Board Tenure | |||||||||||||||||||||||
Years | 3 | 3 | 3 | 3 | 3 | 3 | 3 | ||||||||||||||||
13 |
Board Diversity Matrix (As of September 19, 2024) | ||||||||||||||
Total Number of Directors | 7 | |||||||||||||
Female | Male | Non-Binary | Did Not Disclose Gender | |||||||||||
Part I: Gender Identity | ||||||||||||||
Directors | 2 | 5 | ||||||||||||
Part II: Demographic Background | ||||||||||||||
African American or Black | ||||||||||||||
Alaskan Native or Native American | ||||||||||||||
Asian | ||||||||||||||
Hispanic or Latinx | ||||||||||||||
Native Hawaiian or Pacific Islander | ||||||||||||||
White | 2 | 5 | ||||||||||||
Two or More Races or Ethnicities | ||||||||||||||
LGBTQ+ | ||||||||||||||
Did Not Disclose Demographic Background | ||||||||||||||
14 |
15 |
• | the amount involved, exceeded or will exceed $120,000; and |
• | any directors, executive officers or holders of more than 5% of capital stock of Tilray, or any member of the immediate family of the foregoing persons, had or will have a direct or indirect material interest. |
16 |
Name | Audit Committee | Compensation Committee | Nominating and Governance Committee | ||||||||
Jodi Butts | * | ||||||||||
David Clanachan | * | ||||||||||
John M. Herhalt | + | * | |||||||||
David Hopkinson | * | * | |||||||||
Tom Looney | * | + | |||||||||
Renah Persofsky++ | * | + | |||||||||
Irwin D. Simon ♦ | |||||||||||
* | Committee Member |
+ | Committee Chair |
++ | Vice Chair (Lead Director) |
♦ | Chairman of the Board |
17 |
• | evaluating and retaining a qualified firm to serve as the independent registered public accounting firm to audit our financial statements and continuing to evaluate their performance and qualifications in accordance with the Audit Committee charter; |
• | helping to ensure the independence and performance of the independent registered public accounting firm; |
• | discussing the scope and results of the audit with the independent registered public accounting firm and reviewing, with management and the independent accountants, our interim and year-end operating results; |
• | developing procedures for employees to submit concerns anonymously about questionable accounting or audit matters; |
• | reviewing the results of the Company’s annual and quarterly audits and review of the Company’s financial statements, as appropriate, as well as the Company’s accounting principles and practices; |
• | reviewing our policies on financial risk assessment and risk management; |
• | reviewing related-party transactions; |
• | obtaining and reviewing a report by the independent registered public accounting firm, at least annually, that describes their internal quality-control procedures, any material issues with such procedures and any steps taken to deal with such issues when required by applicable law; and |
• | approving (or, as permitted, pre-approving) all audit and all permissible non-audit service to be performed by the independent registered public accounting firm. |
• | reviewing and approving, or recommending to our Board for approval the compensation of our executive officers; |
• | reviewing and approving, or recommending to our Board for approval the terms of compensatory arrangements with our executive officers; |
• | administering our stock and equity incentive plans; |
• | selecting compensation advisors and assessing whether there are any conflicts of interest with any of the committee’s compensation advisors; |
• | reviewing and approving, or recommending to our Board for approval of the incentive compensation and equity plans, severance agreements, change-of-control protections and any other compensatory arrangements for our executive officers and other senior management, as appropriate; |
18 |
• | reviewing and establishing general policies relating to compensation and benefits of our employees; and |
• | reviewing our overall compensation philosophy. |
• | reviewing and recommending to our Board for approval the compensation of our directors; |
• | reviewing periodically and evaluating director performance on our Board and its applicable committees and recommending to our Board and management areas for improvement; |
• | interviewing, evaluating, nominating and recommending individuals for membership on our Board; |
• | reviewing developments in corporate governance practices; |
• | overseeing and reviewing our processes and procedures to provide information to our Board and its committees; |
• | reviewing and recommending to our Board any amendments to our corporate governance policies; and |
• | reviewing and assessing, at least annually, the performance of the Nominating and Corporate Governance Committee and the adequacy of its charter. |
19 |
20 |
Board of Directors | $140,000 | ||||
Chair of committee: | |||||
Audit | $20,000 | ||||
Compensation | $20,000 | ||||
Nominating and Corporate Governance | $20,000 | ||||
Lead Independent Director: | $90,000 | ||||
Name | Fees Earned or Paid in Cash ($) | Stock Awards ($)(1) | Total ($) | ||||||||
Jodi Butts | 140,000 | 250,000 | 390,000 | ||||||||
David F. Clanachan | 140,000 | 250,000 | 390,000 | ||||||||
John M. Herhalt | 160,000 | 250,000 | 410,000 | ||||||||
David Hopkinson | 140,000 | 250,000 | 390,000 | ||||||||
Thomas Looney | 160,000 | 250,000 | 410,000 | ||||||||
Renah Persofsky | 250,000 | 0 | 250,000 | ||||||||
(1) | This includes FY 2024 RSU equity grants. Ms. Persofsky voluntarily waived her right to an annual RSU equity grant in respect of FY 2024. |
Name | Number of shares Subject to Outstanding Options as of May 31, 2024 | Number of shares Underlying RSUs as of May 31, 2024 | ||||||
Jodi Butts | — | 166,668 | ||||||
David F. Clanachan | — | 133,392 | ||||||
John M. Herhalt | — | 178,581 | ||||||
David Hopkinson | — | 176,143 | ||||||
Thomas Looney | — | 178,581 | ||||||
Renah Persofsky | 30,710 | 63,386 | ||||||
21 |
• | each person, or group of affiliated persons, known by us to beneficially own more than 5% of our Common Stock; |
• | each of our named executive officers; |
• | each of our directors; and |
• | all of our executive officers and directors as a group. |
Common Stock Beneficially Owned | ||||||||
Name of Beneficial Owner | Number | Percent | ||||||
Greater than 5% stockholders: | N/A | N/A | ||||||
Directors and Named Executive Officers: | ||||||||
Irwin D. Simon(1) | 3,246,484 | * | ||||||
Renah Persofsky(2) | 153,628 | * | ||||||
Jodi Butts(3) | 145,778 | * | ||||||
David Clanachan(4) | 112,502 | * | ||||||
John M. Herhalt(5) | 160,741 | * | ||||||
David Hopkinson(6) | 253,936 | * | ||||||
Tom Looney(7) | 275,227 | * | ||||||
Carl Merton(8) | 699,065 | * | ||||||
Denise Faltischek(9) | 784,693 | * | ||||||
Mitchell Gendel(10) | 420,268 | * | ||||||
Roger Savell(11) | 326,839 | * | ||||||
All current executive officers and directors as a group (11 individuals) | 6,579,161 | 0.87% | ||||||
* | Represents less than one percent of the outstanding Common Stock. |
(1) | Represents 3,246,484 shares of Common Stock held directly by Mr. Simon. |
(2) | Represents (a) 63,390 shares of Common Stock held directly by Ms. Persofsky, (b) 30,710 shares underlying options to purchase shares of Common Stock held directly by Ms. Persofsky that have fully vested, and (c) 59,528 restricted (deferred) stock units that have fully vested, which will convert into an equivalent number of shares of Common Stock when Ms. Persofsky ceases to serve as a director of the Company. |
22 |
(3) | Represents (a) 112,502 shares of Common Stock held directly by Ms. Butts, and (b) 33,276 restricted (deferred) stock units that have fully vested, which will convert into an equivalent number of shares of Common Stock when Ms. Butts ceases to serve as a director of the Company. |
(4) | Represents 112,502 shares of Common Stock held directly by Mr. Clanachan. |
(5) | Represents (a) 115,552 shares of Common Stock held directly by Mr. Herhalt, and (b) 45,189 restricted (deferred) stock units that have fully vested, which will convert into an equivalent number of shares of Common Stock when Mr. Herhalt ceases to serve as a director of the Company. |
(6) | Represents (a) 211,185 shares of Common Stock held directly by Mr. Hopkinson and (b) 42,751 restricted (deferred) stock units that have fully vested, which will convert into an equivalent number of shares of Common Stock when Mr. Hopkinson ceases to serve as a director of the Company. |
(7) | Represents (a) 230,038 shares of Common Stock held directly by Mr. Looney, and (b) 45,189 restricted (deferred) stock units that have fully vested, which will convert into an equivalent number of shares of Common Stock when Mr. Looney ceases to serve as a director of the Company. |
(8) | Represents (a) 660,055 shares of Common Stock held directly by Mr. Merton, (b) 20,750 shares of Common Stock issuable pursuant to restricted stock units held directly by Mr. Merton that have fully vested and (c) 18,260 restricted (deferred) stock units that have fully vested, which will convert into an equivalent number of shares of Common Stock when Mr. Merton ceases to serve as an officer of the Company. |
(9) | Represents (a) 535,693 shares of Common Stock held directly by Ms. Faltischek and (b) 249,000 shares of Common Stock that are issuable upon the exercise of options held directly by Ms. Faltischek that have fully vested. |
(10) | Represents 420,268 shares of Common Stock held directly by Mr. Gendel. |
(11) | Represents 326,839 shares of Common Stock held directly by Mr. Savell. |
23 |
• | enhance stockholder value by aligning the financial interests of our NEOs with those of our stockholders; |
• | enable us to attract, motivate and retain the people needed to support our long-term goal of being an industry leader; |
• | integrate compensation closely with the achievement of our business and performance objectives; and |
• | reward the individual performance that contributes to our short-term and long-term successes. |
• | a program structure to attract, motivate and retain a highly qualified executive management team. |
• | linking executive compensation to key corporate objectives, including near-term product development and business development goals, as well as to define individual management objectives established by the Compensation Committee; |
• | compensate competitively with the practices of similarly staged companies; and |
• | create management incentives designed to enhance stockholder value. |
24 |
• | Successfully identified, completed and integrated three (3) strategic acquisition targets, including HEXO Corp. in Canada (acquisition closed July 2023); eight (8) AB craft beverages in the U.S. (acquisition closed in October 2023); and Truss beverages in Canada (acquisition of controlling interest closed in September 2023 and subsequent sale closed in May 2024). Management effectively consolidated and integrated each of these acquired businesses and exceeded all applicable cost-saving targets and facility optimization goals. |
• | Achieved a reduction of net leverage ratio at Fiscal Year-end 2024 equal to 1.73, significantly better than the applicable financial target of 2.50 net leverage ratio at Fiscal Year-end 2024. |
• | Achieved 26% net revenue growth and net revenues of $789 million for Fiscal Year 2024, as compared to revenue target of $715 million. The applicable financial revenue target was not fully achieved if acquisitions were excluded from the applicable calculation. |
• | Adjusted EBITDA1 for Fiscal Year 2024 was equal to $60.5 million, as compared to the adjusted EBITDA target of $65 million and investor guidance of $60–63 million. Therefore, despite improved adjusted EBITDA performance in 2024 as compared to Fiscal Year 2023, and despite achieving revised investor guidance, this performance target was determined not to be fully achieved. |
What We Do | What We Don’t Do | ||||||||||
✔ | Pay for Performance – majority of compensation “at risk” | ✘ | Permit short sales by directors, officers or employees | ||||||||
✔ | Reasonable post-employment and change in control provisions | ✘ | Allow hedging or pledging of Company stock | ||||||||
✔ | Stock ownership guidelines | ✘ | Offer change in control tax gross-ups | ||||||||
✔ | Use of Multiple Performance Metrics | ✘ | Permit repricing of underwater options without stockholder approval | ||||||||
✔ | Clawback Policy for equity incentive awards and cash bonuses in the event of restatement of financial results | ✘ | Offer unreasonable perquisites | ||||||||
✘ | No single trigger cash severance based solely on a change in control of the Company | ||||||||||
1 | Adjusted EBITDA is a non-GAAP financial measure. Please see “Reconciliation of Non-GAAP Financial Measures to GAAP Measures” in our Annual Report on Form 10-K for the fiscal year ended May 31, 2024 for a reconciliation of such non-GAAP Measures to the most directly comparable GAAP financial measures. |
25 |
Tilray Named Executive Officers as of May 31, 2024 | ||||||||
Name | Position | Age | ||||||
Irwin Simon | President, Chief Executive Officer and Chairman of the Board (“CEO”) | 66 | ||||||
Carl Merton | Chief Financial Officer | 55 | ||||||
Denise Faltischek | Chief Strategy Officer and Head of International | 51 | ||||||
Mitchell Gendel | Global General Counsel and Corporate Secretary | 59 | ||||||
Roger Savell | Chief Administrative Officer | 62 | ||||||
26 |
1. | Industry: Focus was given to companies in the cannabis industry as this best represents the main customer, labor and capital markets in which Tilray competes; however, given Tilray is larger than other cannabis companies, it was important to assess other industries as well. |
• | Broader biotechnology / pharmaceuticals companies were included because they are similar to Tilray’s medical cannabis business in many respects. |
• | Companies in the consumer-packaged goods industry were also considered due to Tilray’s consumer-product based business model, and Tilray’s expansion of products and services in the brewery and distillery industry. |
• | Because the Company’s operations span multiple industries, the Committee also believes that a consistent approach across the breadth of the Company’s operations with respect to features of our overall executive compensation structure is best achieved by reference to a group of general industry peers that is broader than the cannabis, biotechnology, and consumer-packaged goods industry peers. |
2. | Size: Company size is a strong indicator of organizational complexity and drives scope of accountability. |
• | Given the anticipated growth of Tilray following the Business Combination and the cannabis sector overall, a wider financial lens was applied by Korn Ferry, and revenue was the primary indicator of size. Total assets and market capitalization were used as secondary reference points. |
3. | Operations: As Tilray is an established international operator in the cannabis industry, focus was given to companies that are based in North America and have international operations. |
4. | Location: The regions or countries where Tilray competes for talent. Our approach proposes to focus the executive compensation analysis primarily to Canadian and U.S.-based companies. |
• | Since Tilray is U.S.-based with Canadian and U.S.-sourced executives, the Canadian and U.S. markets are both relevant sources of data. Should other markets become relevant in the future, consideration will be given to including companies from those geographies in Tilray’s peer group. |
Cannabis Companies Canopy Growth Corporation Curaleaf Holdings, Inc. | Cresco Labs, Inc. Green Thumb Industries, Inc. | GW Pharmaceuticals plc Trulieve Cannabis Corp. | ||||||
Biotechnology/Pharmaceutical/Technology Companies Catalent, Inc. DocuSign, Inc. | Etsy, Inc. Incyte Corporation | Neurocrine Biosciences, Inc. Unity Software Inc. | ||||||
Consumer Packaged Goods/Alcohol Companies Beyond Meat Constellation Brands, Inc. | Monster Beverage National Beverage | The Boston Beer Company, Inc. The Simply Good Food Co. | ||||||
27 |
28 |
Compensation Element | Primary Purpose | Performance Period | Details | |||||||||||||||||
Cash Compensation | ||||||||||||||||||||
Base Salary | • | Fixed annual compensation for ongoing services performed, executive tenure, and role | • | Ongoing | • | Provided in cash each pay period. Intended to be competitive in marketplace and to retain key employees | ||||||||||||||
• | Continuity | |||||||||||||||||||
Annual Performance-based Bonus | • | Reinforce and drive short-term priorities and business results | • | 1 year | • | Target award based on a percentage of salary; limited to 100% of base salary for senior executives (except for the CEO whose percentages range from 200% to 350% of salary) | ||||||||||||||
• | Recognize and reward corporate, and business, and individual performance, including for awards for material transactions | • | Incentivizes and rewards the achievement of predetermined corporate and business short-term objectives that are aligned with our strategic plan as well as individual performance | |||||||||||||||||
Equity Award Compensation | ||||||||||||||||||||
EBITDA PSU Awards (as described below) | • | Reinforce and drive long-term stockholder value | • | Generally, 3 years | • | The Compensation Committee issued at-risk grants to the NEOs in July 2023 and April 2024 that included both time and performance-based vesting terms and conditions | ||||||||||||||
• | At risk equity awards based on achievement of Company’s financial performance and benefits | |||||||||||||||||||
Annual Long-term incentives (LTIP RSUs) | • | Reinforce and drive long-term stockholder value | • | 2 years | • | Annual grants of LTIP RSUs: The grant value is based on applicable market-driven metrics level and percentage of salary with 50% of the shares vesting one year from the vesting commencement date and the remaining 50% of the shares vesting on the second anniversary of the grant date. | ||||||||||||||
• | Retention of key employees during applicable performance periods | |||||||||||||||||||
29 |
• | Financial Performance Measures. The financial metrics used to determine the amount of an executive’s bonus are measures the Committee believes drive long-term stockholder value. The ranges set for these measures are intended to reward success without encouraging excessive risk-taking. |
• | No Hedging or Pledging. The Company’s insider trading compliance program prohibits members of the Board of Directors, NEOs and all other employees subject to the Company’s insider trading compliance program from entering into any transaction designed to hedge, or having the effect of hedging, the economic risk of owning the Company’s securities, and prohibits these persons from pledging Company securities. |
• | Insider Trading Policies and Procedures. The Board has adopted an insider trading and trading window policy (the “ |
• | Clawback Policy. Pursuant to the terms of the Company’s 2018 Amended and Restated Tilray Brands, Inc. Equity Incentive Plan (the “2018 Equity Plan”), if the Company is required to restate its financial results due to material noncompliance with financial reporting requirements under the securities laws as a result of misconduct by an executive officer, applicable law permits the Company to recover equity incentive compensation from that executive officer (including profits realized from the sale of Company securities). In such a situation, the Board would exercise its business judgment to determine what action it believes is appropriate. Action may include recovery or cancellation of any equity incentive award made to an executive on the basis of having met or exceeded performance targets during a period of fraudulent activity or a material misstatement of financial results if the Board determines that such recovery or cancellation is appropriate due to intentional misconduct by the executive officer that resulted in performance targets being achieved that would not have been achieved absent such misconduct. |
30 |
31 |
Name | Fiscal Year 2024 Base Salary | ||||
Irwin Simon | $1,891,760 | ||||
Carl Merton(1) | $388,304 | ||||
Denise Faltischek | $600,000 | ||||
Mitchell Gendel | $560,000 | ||||
Roger Savell | $525,000 | ||||
(1) | The salary of Mr. Merton is converted into USD with an exchange rate on May 31, 2024 of $0.7326 (USD) to $1.0000 (CAD). The annual salary of Mr. Merton is $530,000 (CAD). |
• | Successfully identified, completed and integrated three (3) strategic acquisition targets, including HEXO Corp. in Canada (acquisition closed July 2023); eight (8) AB craft beverages in the U.S. (acquisition closed in October 2023); and Truss beverages in Canada (acquisition of controlling interest closed in September 2023 and subsequent sale closed in May 2024). Management effectively consolidated and integrated each of these acquired businesses and exceeded all applicable cost-saving targets and facility optimization goals. |
• | Achieved reduction of net leverage ratio at Fiscal Year-end 2024 equal to 1.73, significantly better than the applicable financial target of 2.50 net leverage ratio at Fiscal Year-end 2024. |
• | Achieved 26% net revenue growth and net revenues of $789 million for Fiscal Year 2024, as compared to revenue target of $715 million. The applicable financial revenue target was not fully achieved if acquisitions were excluded from the applicable calculation. |
• | Adjusted EBITDA2 for Fiscal Year 2024 was equal to $60.5 million, as compared to the adjusted EBITDA target of $65 million and investor guidance of $60–63 million. Therefore, despite improved adjusted EBITDA performance in 2024 as compared to Fiscal Year 2023, and despite achieving revised investor guidance, this performance target was determined not to be fully achieved. |
2 | Adjusted EBITDA is a non-GAAP financial measure. Please see “Reconciliation of Non-GAAP Financial Measures to GAAP Measures” in our Annual Report on Form 10-K for the fiscal year ended May 31, 2024 for a reconciliation of such non-GAAP Measures to the most directly comparable GAAP financial measures. |
32 |
Name | Target Bonus Percentage of Base salary | Bonus Target Amount ($) | Bonus Amount ($) Paid for Fiscal Year 2024 | ||||||||
Irwin Simon | 200% (up to a maximum of 350%) | $3,783,520 (maximum of $6,621,160) | $1,040,000 | ||||||||
Carl Merton | 100% | $388,304 | $77,661 | ||||||||
Denise Faltischek | 100% | $600,000 | $120,000 | ||||||||
Mitchell Gendel | 100% | $560,000 | $112,000 | ||||||||
Roger Savell | 100% | $525,000 | $155,000 | ||||||||
• | the competitive equity compensation practices for comparable positions identified in the applicable market analysis; |
• | the executive’s level of responsibility and duties; |
• | a comparison to grant levels of other executive officers; |
• | individual NEOs’ performance; |
• | our corporate performance; |
• | our total equity compensation costs relative to total expenses; |
• | the executive’s prior experience, experience within his or her specific job and breadth of knowledge; and |
• | our corporate objectives for share-based compensation charges and earnings dilution. |
33 |
Name | Total Value of PSUs assuming Target Achievement (100%) | ||||
Irwin D. Simon | $16,995,828 | ||||
Carl Merton | $2,386,684 | ||||
Denise Faltischek | $2,420,980 | ||||
Roger Savell | $1,734,504 | ||||
Mitchell Gendel | $2,102,824 | ||||
34 |
Name | Total Annual LTIP RSUs | Annual LTIP RSU Target Percentage of Base Salary | ||||||
Irwin Simon | 2,356,218 | 250% | ||||||
Carl Merton | 348,954 | 175% | ||||||
Denise Faltischek | 498,705 | 175% | ||||||
Mitchell Gendel | 462,435 | 175% | ||||||
Roger Savell | 453,368 | 175% | ||||||
35 |
• | Chief Executive Officer: 3× base salary |
• | Independent Directors 2× base annual cash retainer |
• | Chief Financial Officer 1× base salary |
• | Other Officers 0.5× base salary |
36 |
37 |
Name and Principal Position | Fiscal Year | Salary ($)(1) | Bonus ($) | Stock Awards ($)(2) | Non-Equity Incentive Plan Compensation(3) | Option Awards | All Other Compensation ($)(4) | Total ($) | ||||||||||||||||||
Irwin Simon President, Chief Executive Officer and Chairman of the Board | 2024 | 1,891,760 | 2,500,000(6) | 4,547,501 | 1,040,000 | — | 163,710 | 10,142,971 | ||||||||||||||||||
2023 | 1,819,000 | 2,500,000(5) | 9,249,999 | 1,909,950 | — | 177,635 | 15,656,584 | |||||||||||||||||||
2022 | 1,714,165 | — | 17,599,962 | — | — | 142,639 | 19,456,767 | |||||||||||||||||||
Carl Merton Chief Financial Officer | 2024 | 388,304(7) | 500,000(6) | 673,481 | 77,661 | — | 13,553 | 1,652,999 | ||||||||||||||||||
2023 | 373,358(7) | 475,000(5) | 1,321,687 | 112,026 | — | 11,049 | 2,293,120 | |||||||||||||||||||
2022 | 375,086(7) | — | 2,447,902 | — | — | 13,412 | 2,836,400 | |||||||||||||||||||
Denise Faltischek Chief Strategy Officer and Head of International | 2024 | 600,000 | 600,000(6) | 962,501 | 120,000 | — | 34,581 | 2,317,082 | ||||||||||||||||||
2023 | 550,000 | 600,000(5) | 1,539,999 | 165,000 | — | 107,681 | 2,962,680 | |||||||||||||||||||
2022 | 509,615 | — | 2,365,606 | — | — | 15,125 | 2,890,346 | |||||||||||||||||||
Roger Savell(8) Chief Administrative Officer | 2024 | 525,000 | 550,000(6) | 875,000 | 155,000 | — | 27,669 | 2,132,670 | ||||||||||||||||||
2023 | 500,000 | 75,000(5) | 810,833 | 150,000 | 97,465 | 1,633,298 | ||||||||||||||||||||
Mitchell Gendel(9) Global General Counsel and Corporate Secretary | 2024 | 560,000 | 550,000(6) | 892,500 | 112,000 | — | 29,967 | 2,144,466 | ||||||||||||||||||
2023 | 510,000 | 500,000(5) | 1,408,750 | 153,000 | — | 26,870 | 2,598,620 | |||||||||||||||||||
2022 | 370,512 | — | 1,999,995 | — | — | 16,297 | 2,386,804 | |||||||||||||||||||
(1) | Each of the named executive officers received a base salary increase effective as of June 1, 2024. |
(2) | These amounts reported do not reflect the amounts actually received by our NEOs. Instead, these amounts reflect the aggregate grant date fair value of each stock option or restricted stock unit award granted to our NEOs on each of July 26, 2021 (during Fiscal Year 2022); July 26, 2022 (during Fiscal Year 2023); and July 26, 2023 (during Fiscal Year 2024), as computed in accordance with Financial Accounting Standards Board, or FASB, Accounting Standards Codification, or ASC 718. Assumptions used in the calculation of the grant date fair value of each equity award are included in Note 19 to our consolidated financial statements included in our Annual Report on Form 10-K for the year ended May 31, 2024. |
(3) | Represents the cash performance bonus earned under our Annual Performance Bonus Plan described above. |
(4) | Further details for Fiscal Year 2024 are included in the “All Other Compensation” table below. |
(5) | These amounts include transaction bonuses paid to our NEOs in August 2022 (Fiscal Year 2023) in recognition of the HEXO convertible debt investment. |
(6) | These amounts include transaction bonuses paid to our NEOs in August 2023 (Fiscal Year 2024) in recognition of successful closing of the HEXO acquisition. |
38 |
(7) | The 2024 compensation of Mr. Merton is converted into USD with the exchange rate of May 31, 2024 of $0.7326 (USD) to $1.0000 (CAD). The 2023 compensation of Mr. Merton is converted into USD with the exchange rate of May 31, 2023 of $0.7346 (USD) to $1.0000 (CAD). The 2022 compensation of Mr. Merton is converted into USD with an exchange rate on May 31, 2022 of $0.7899 (USD) to $1.0000 (CAD). |
(8) | Mr. Savell was hired as Chief Administrative Officer on March 31, 2022. No information is reported for 2022; he was not an NEO for that fiscal year. |
(9) | Mr. Gendel was hired as Global General Counsel and Corporate Secretary on July 17, 2021. |
NEO | Car Allowance | 401(k) Contributions | GLT-FICA | Health & Welfare Benefits | Life Insurance Premiums | Total | ||||||||||||||
Irwin Simon | $20,781 | $6,186 | $889 | $20,261 | $115,593 | $163,710 | ||||||||||||||
Carl Merton | $10,990 | $0 | $0 | $2,563 | $0 | $13,553 | ||||||||||||||
Denise Faltischek | $0 | $14,033 | $161 | $20,387 | $0 | $34,581 | ||||||||||||||
Mitchell Gendel | $0 | $14,033 | $301 | $15,633 | $0 | $29,967 | ||||||||||||||
Roger Savell | $0 | $13,617 | $462 | $13,591 | $0 | $27,669 | ||||||||||||||
Estimated Possible Payouts Under Non-Equity Incentive Plan | Estimated Possible Payouts Under Equity Incentive Plan(1) | Grant Date fair value of Equity Awards(2) | ||||||||||||||||||||||||
Name | Grant date | Target | Maximum | Target | Maximum | Target | Maximum | Type | ||||||||||||||||||
Irwin Simon | 26-Jul-23 | 2,356,218 | 2,356,218 | $4,547,501 | $4,547,501 | Annual LTIP Incentive | ||||||||||||||||||||
26-Jul-23 | 4,403,064 | 4,403,064 | — | — | 2024 EBITDA PSU Awards | |||||||||||||||||||||
5-Apr-24 | 4,403,064 | 4,403,064 | — | — | 2024 EBITDA PSU Awards | |||||||||||||||||||||
$3,783,520 | $6,621,160 | |||||||||||||||||||||||||
Carl Merton | 26-Jul-23 | 348,954 | 348,954 | $673,481 | $673,481 | Annual LTIP Incentive | ||||||||||||||||||||
26-Jul-23 | 618,311 | 618,311 | — | — | 2024 EBITDA PSU Awards | |||||||||||||||||||||
5-Apr-24 | 618,311 | 618,311 | — | — | 2024 EBITDA PSU Awards | |||||||||||||||||||||
$388,304 | $388,304 | |||||||||||||||||||||||||
Denise Faltischek | 26-Jul-23 | 498,705 | 498,705 | $962,501 | $962,501 | Annual LTIP Incentive | ||||||||||||||||||||
26-Jul-23 | 627,197 | 627,197 | — | — | 2024 EBITDA PSU Awards | |||||||||||||||||||||
5-Apr-24 | 627,197 | 627,197 | — | — | 2024 EBITDA PSU Awards | |||||||||||||||||||||
$600,000 | $600,000 | |||||||||||||||||||||||||
Roger Savell | 26-Jul-23 | 453,368 | 453,368 | $875,000 | $875,000 | Annual LTIP Incentive | ||||||||||||||||||||
26-Jul-23 | 449,353 | 449,353 | — | — | 2024 EBITDA PSU Awards | |||||||||||||||||||||
5-Apr-24 | 449,353 | 449,353 | — | — | 2024 EBITDA PSU Awards | |||||||||||||||||||||
$525,000 | $525,000 | |||||||||||||||||||||||||
Mitchell Gendel | 26-Jul-23 | 462,435 | 462,435 | $892,500 | 892,500 | Annual LTIP Incentive | ||||||||||||||||||||
26-Jul-23 | 544,773 | 544,773 | — | — | 2024 EBITDA PSU Awards | |||||||||||||||||||||
5-Apr-24 | 544,773 | 544,773 | — | — | 2024 EBITDA PSU Awards | |||||||||||||||||||||
$560,000 | $560,000 | |||||||||||||||||||||||||
(1) | The share amounts in this column for the awards labeled “2024 EBITDA PSU Awards” represent the number of shares granted on the grant date for 2024 EBITDA PSU Awards. These awards are described in the Compensation Discussion & Analysis section under “2024 EBITDA PSU Awards” granted during Fiscal Year 2024, and did not have a fair value for purposes of ASC 718 on the grant date due to the three-year cumulative performance targets not having been set during Fiscal Year 2024. Therefore, there is no corresponding dollar amount for the 2024 EBITDA PSU Awards included in the Grant of Plan-Based Awards table. In addition, the 2024 EBITDA PSU Awards that were made in April 2024 represent a contingent right to receive a cash payment or its equivalent in shares of Common Stock (as determined by the Compensation Committee). See footnote 2 to the Summary Compensation Table for a discussion of the value of the 2024 EBITDA PSU Awards based on the value of a share of Company common stock as of the date of grant. |
(2) | The dollar amounts in this column represent the grant date fair value of the product of the number of shares granted and the closing market price of our common stock on the grant date for time-based restricted stock units. These annual LTIP grants vest at the rate of 50% of the RSUs on the twelve (12) month anniversary of the grant date (the “Vesting Date”), and the remaining 50% RSUs on the 24 months anniversary of the Vesting Date. |
39 |
Option Awards | Stock Awards | ||||||||||||||||||||||||||||
Name | Grant Date | Type of Award | Vesting Commencement date | Number of securities underlying unexercised options (#) exercisable | Number of securities underlying unexercised options (#) unexercisable | Operation exercise price ($) | Option expiration date | Number of shares or units of stock that have not vested (#) | Market value of shares of units of stock that have not vested ($) | ||||||||||||||||||||
Irwin Simon | 8/7/2019(1) | APH Ex | 8/7/2019 | 31,887 | — | 8.95 | 8/7/2024 | — | — | ||||||||||||||||||||
7/27/2021(2) | EIP 2018 | 6/1/2021 | — | — | — | — | 130,951 | 235,712 | |||||||||||||||||||||
7/27/2021(3) | EIP 2018 | 7/27/2021 | — | — | — | — | 392,772 | 706,990 | |||||||||||||||||||||
7/27/2021(4) | EIP 2018 | 7/27/2021 | — | — | — | — | 49,097 | 88,375 | |||||||||||||||||||||
7/27/2021(4) | EIP 2018 | 7/27/2021 | — | — | — | — | 49,097 | 88,375 | |||||||||||||||||||||
7/26/2022(5) | EIP 2018 | 6/1/2022 | — | — | — | — | 600,283 | 1,080,509 | |||||||||||||||||||||
7/26/2022(6) | EIP 2018 | 7/26/2022 | — | — | — | — | 1,412,430 | 2,542,374 | |||||||||||||||||||||
7/26/2023(5) | EIP 2018 | 6/1/2023 | — | — | — | — | 2,356,218 | 4,241,192 | |||||||||||||||||||||
7/26/2023(8) | EIP 2018 | 7/26/2023 | — | — | — | — | 4,403,064 | 7,925,515 | |||||||||||||||||||||
4/5/2024(8) | EIP 2018 | 6/1/2024 | 4,403,064 | 7,925,515 | |||||||||||||||||||||||||
Carl Merton | 7/26/2021(3) | EIP 2018 | 7/26/2021 | — | — | — | — | 48,662 | 87,592 | ||||||||||||||||||||
7/26/2021(4) | EIP 2018 | 7/26/2021 | — | — | — | — | 6,083 | 10,949 | |||||||||||||||||||||
7/26/2021(4) | EIP 2018 | 7/26/2021 | — | — | — | — | 6,083 | 10,949 | |||||||||||||||||||||
7/26/2021(2) | EIP 2018 | 6/1/2021 | — | — | — | — | 16,224 | 29,203 | |||||||||||||||||||||
7/26/2022(5) | EIP 2018 | 6/1/2022 | — | — | — | — | 92,753 | 166,955 | |||||||||||||||||||||
7/26/2022(6) | EIP 2018 | 7/26/2022 | — | — | — | — | 187,854 | 338,137 | |||||||||||||||||||||
7/26/2023(5) | EIP 2018 | 6/1/2023 | — | — | — | — | 348,954 | 628,117 | |||||||||||||||||||||
7/26/2023(8) | EIP 2018 | 7/26/2023 | — | — | — | — | 618,311 | 1,112,960 | |||||||||||||||||||||
4/5/2024(8) | EIP2018 | 6/1/2024 | 618,311 | 1,112,960 | |||||||||||||||||||||||||
40 |
Option Awards | Stock Awards | ||||||||||||||||||||||||||||
Name | Grant Date | Type of Award | Vesting Commencement date | Number of securities underlying unexercised options (#) exercisable | Number of securities underlying unexercised options (#) unexercisable | Operation exercise price ($) | Option expiration date | Number of shares or units of stock that have not vested (#) | Market value of shares of units of stock that have not vested ($) | ||||||||||||||||||||
Denise Faltischek | 10/17/2019(7) | APH Ex | 10/17/2019 | 249,000 | — | 6.50 | 10/17/2024 | — | — | ||||||||||||||||||||
7/26/2021(2) | EIP 2018 | 6/1/2021 | — | — | — | — | 16,224 | 29,203 | |||||||||||||||||||||
7/26/2021(3) | EIP 2018 | 7/26/2021 | — | — | — | — | 48,662 | 87,592 | |||||||||||||||||||||
7/26/2021(4) | EIP 2018 | 7/26/2021 | — | — | — | — | 6,083 | 10,949 | |||||||||||||||||||||
7/26/2021(4) | EIP 2018 | 7/26/2021 | — | — | — | — | 6,083 | 10,949 | |||||||||||||||||||||
7/26/2022(5) | EIP 2018 | 6/1/2022 | — | — | — | — | 123,588 | 222,458 | |||||||||||||||||||||
7/26/2022(6) | EIP 2018 | 7/31/2022 | — | — | — | — | 187,854 | 338,137 | |||||||||||||||||||||
7/26/2023(5) | EIP 2018 | 6/1/2023 | — | — | — | — | 498,705 | 897,669 | |||||||||||||||||||||
7/26/2023(8) | EIP 2018 | 7/26/2023 | — | — | — | — | 627,197 | 1,128,955 | |||||||||||||||||||||
4/5/2024(8) | EIP2018 | 6/1/2024 | 627,197 | 1,128,955 | |||||||||||||||||||||||||
Roger Savell | 4/5/2022(2) | EIP 2018 | 4/5/2022 | — | — | — | 29,830 | 53,694 | |||||||||||||||||||||
4/5/2022(4) | EIP 2018 | 4/5/2022 | — | — | — | — | 11,186 | 20,135 | |||||||||||||||||||||
4/5/2022(4) | EIP 2018 | 4/5/2022 | — | — | — | — | 11,186 | 20,135 | |||||||||||||||||||||
4/5/2022(3) | EIP 2018 | 4/5/2022 | — | — | — | — | 89,485 | 161,073 | |||||||||||||||||||||
7/26/2022(6) | EIP 2018 | 7/26/2022 | — | — | — | — | 187,854 | 338,137 | |||||||||||||||||||||
7/26/2022(5) | EIP 2018 | 6/1/2022 | — | — | — | — | 20,598 | 37,076 | |||||||||||||||||||||
7/26/2023(5) | EIP 2018 | 6/1/2023 | — | — | — | — | 453,368 | 816,062 | |||||||||||||||||||||
7/26/2023(8) | EIP 2028 | 7/26/2023 | — | — | — | — | 449,353 | 808,8358 | |||||||||||||||||||||
4/5/2024(8) | EIP2018 | 6/1/2024 | 449,353 | 08,835 | |||||||||||||||||||||||||
Mitchell Gendel | 7/26/2021(4) | EIP 2018 | 7/26/2021 | — | — | — | — | 6,083 | 10,049 | ||||||||||||||||||||
7/26/2021(4) | EIP 2018 | 7/26/2021 | — | — | — | — | 6,083 | 10,049 | |||||||||||||||||||||
7/26/2021(2) | EIP 2018 | 6/1/2021 | — | — | — | — | 16,224 | 29,203 | |||||||||||||||||||||
7/26/2021(3) | EIP 2018 | 7/26/2021 | — | — | — | — | 48,662 | 87,592 | |||||||||||||||||||||
7/26/2022(5) | EIP 2018 | 6/1/2022 | — | — | — | — | 105,050 | 189,090 | |||||||||||||||||||||
7/26/2022(6) | EIP 2018 | 7/26/2022 | — | — | — | — | 187,854 | 338,137 | |||||||||||||||||||||
7/26/2023(5) | EIP 2018 | 6/1/2023 | — | — | — | — | 462,435 | 832,383 | |||||||||||||||||||||
7/26/2023(8) | EIP 2028 | 7/26/2023 | — | — | — | — | 544,773 | 980,5919 | |||||||||||||||||||||
4/5/2024(8) | EIP 2018 | 6/1/2024 | 544,773 | 80,591 | |||||||||||||||||||||||||
(1) | The options vest in three years with 1/3 of the options vesting on each anniversary of the vesting commencement date through the third anniversary of the vesting commencement date. |
(2) | The award vests in three years with 1/3 of the award vesting on each anniversary of the vesting commencement date through the third anniversary of the vesting commencement date. |
(3) | 100% of the award vests on December 31, 2025. |
(4) | The award vests in three years with 50% of the award vesting on the first anniversary of the vesting commencement date and 25% of the award vesting on each of the second and third anniversary of the vesting commencement date. |
(5) | The award vests in tranches over two years with 50% of the shares subject to the awards vesting one year from the vesting commencement date and the remaining 50% of shares vesting on the second anniversary of the vesting commencement date. |
(6) | The award vests in three years with 50% of the award vesting on July 31, 2023, 25% of the award vesting on July 31, 2024, and 25% of the award vesting on July 31, 2025. |
(7) | The options vested on the grant date and will expire on October 17, 2024. |
(8) | The award has a three-year performance period beginning on June 1, 2023, and ending on May 31, 2026. The awards will vest as of the end of the performance period (May 31, 2026) subject to the NEO’s continuous service, but will not settle and payout until the percentage of the awards earned is determined by the Compensation Committee in July 2026 subject to the satisfaction of the cumulative performance goals. |
41 |
Option Awards | Stock Awards | |||||||||||||
Name | Number of Shares Acquired on Exercise (#) | Value Realized on Exercise ($) | Number of Shares Acquired on Vesting (#) | Value Realized on Vesting ($) | ||||||||||
Irwin Simon | — | — | 1,064,119 | $5,209,741 | ||||||||||
Carl Merton | — | — | 162,144 | $715,546 | ||||||||||
Denise Faltischek | — | — | 172,872 | $762,170 | ||||||||||
Roger Savell | — | — | 126,146 | $617,818 | ||||||||||
Mitchell Gendel | — | — | 157,267 | $704,902 | ||||||||||
42 |
43 |
44 |
45 |
46 |
47 |
• | We identified our median employee from all employees, including full-time and part-time employees who were on our payroll records as of a determination date of May 31, 2024. |
• | Compensation for international employees was converted to U.S. dollar equivalents based on the applicable exchange rate. |
• | In determining compensation for purposes of the median calculation, we used each employee’s annual base pay and cash equivalent of benefits. |
• | We annualized the base salary earned during the fiscal year ending May 31, 2024 by all employees. |
• | We then calculated the annual total base compensation of the identified median employee in accordance with the requirements of the Summary Compensation Table. |
48 |
Base salary | Bonus | Equity Awards | Benefits | Total | ||||||||||||||||
Severance Period (months) | Amount of base pay | Value | Value Unvested Estimates (Max)(1) | COBRA(4)/ Equivalent | Total | |||||||||||||||
Irwin Simon | ||||||||||||||||||||
Termination Without Cause or for Good Reason(2) | 18 | $2,837,640 | $5,675,280 | $8,276,537 | $28,481 | $16,817,938 | ||||||||||||||
Change of Control | 30 | $4,729,400 | $9,458,800 | $25,406,956 | $47,469 | $39,642,624 | ||||||||||||||
Carl Merton(3) | ||||||||||||||||||||
Termination Without Cause or for Good Reason | 12 | $388,304 | $388,304 | $1,184,312 | $3,076 | $1,963,995 | ||||||||||||||
Change of Control | 24 | $776,608 | $776,608 | $3,578,205 | $3,076 | $5,134,497 | ||||||||||||||
Denise Faltischek | ||||||||||||||||||||
Termination Without Cause or for Good Reason | 12 | $600,000 | $600,000 | $1,509,367 | $18,987 | $2,728,354 | ||||||||||||||
Change of Control | 24 | $1,200,000 | $1,200,000 | $3,936,403 | $18,987 | $6,355,390 | ||||||||||||||
Roger Savell | ||||||||||||||||||||
Termination Without Cause or for Good Reason | 12 | $525,000 | $525,000 | $1,285,240 | $12,191 | $2,347,431 | ||||||||||||||
Change of Control | 24 | $1,050,000 | $1,050,000 | $3,122,400 | $12,191 | $5,234,591 | ||||||||||||||
Mitchell Gendel | ||||||||||||||||||||
Termination Without Cause or for Good Reason | 12 | $560,000 | $560,000 | $1,410,712 | $14,233 | $2,544,945 | ||||||||||||||
Change of Control | 24 | $1,120,000 | $1,120,000 | $3,530,307 | $14,233 | $5,784,540 | ||||||||||||||
(1) | For all NEOs, the value of equity award acceleration of vesting is based on the closing stock price of $1.80 per share of our common stock as reported on the Nasdaq Global Select Market on May 31, 2024, and based on a 100% target vesting. |
(2) | Mr. Simon is also entitled to certain payments upon termination of employment due to death or disability. |
(3) | The amounts shown for Mr. Merton are converted into USD with an exchange rate of $0.7326 (USD) to $1.0000 (CAD). |
(4) | COBRA calculations are based on current employer paid benefits as of May 31, 2024, for medical and dental coverage and based on family status. |
49 |
50 |
Current PEO2 | Prior PEO2 | Average of Non-PEO NEOs3 | Value of $100 Initial Investment Based On: | Net Income (Loss)10 ($000) | Adjusted EBITDA11 ($000) | |||||||||||||||||||||||||||
Fiscal Year1 | SCT Total Compensation4 | Compensation Actually Paid5 13 | SCT Total Compensation4 | Compensation Actually Paid6 | SCT Total Compensation4 | Compensation Actually Paid7 13 | Cumulative TSR8 | Peer Group TSR9 | ||||||||||||||||||||||||
2024 | $ | $ | $ | $ | $ | $ | $ | $ | ($ | $ | ||||||||||||||||||||||
2023 | $ | $ | $ | $ | $ | $ | $ | $ | ($ | $ | ||||||||||||||||||||||
2022 | $ | $ | $ | $ | $ | $ | $ | $ | ($ | $ | ||||||||||||||||||||||
2021 | $ | $ | $ | $ | $ | $ | $ | $ | ($ | $ | ||||||||||||||||||||||
2020 | $ | $ | $ | ($ | $ | $ | $ | $ | ($ | $ | ||||||||||||||||||||||
(1) | In accordance with the transitional relief under the SEC rules, only three fiscal years ending May 31st of information is required as this is the Company’s first fiscal year of disclosure under Item 402(v) of Regulation S-K, with an additional year added in each of the two subsequent years of compliance. Fiscal year 2021 was a five-month transition period (January 1, 2021 to May 31, 2021) due to the change in the Company’s fiscal year-end. For 2020, the reportable year was January 1, 2020 to December 31, 2020. |
(2) | In fiscal year 2021, the PEOs included |
(3) | The non-PEO NEOs for the applicable fiscal years were as follows: |
(4) | The values in this column reflect the “Total” compensation set forth in the Summary Compensation Table (“SCT”) as stated in the Company’s past proxy filings for the corresponding fiscal year. See the footnotes to the applicable SCT for further detail regarding the amounts in this column. |
51 |
(5) | The following table sets forth the adjustments made during each fiscal year presented in the Pay Versus Performance Table to arrive at compensation “actually paid” to our Current PEO during 2021, 2022, 2023, and 2024: |
Adjustments to Determine Compensation “Actually Paid” for Current PEO | SCT Total Compensation4 | Deduction for Amounts Reported under the “Stock Awards” and “Option Awards” Column in the SCT | Increase for Fair Value of Awards Granted during the year that Remain Unvested as of Year End | Increase for Fair Value of Awards Granted during the year that Vest during year | Increase/ deduction for Change in Fair Value from prior Year-end to current Year-end of Awards Granted Prior to year that were Outstanding and Unvested as of Year-end | Increase/ deduction for Change in Fair Value from Prior Year-end to Vesting Date of Awards Granted Prior to year that Vested during year | Deduction of Fair Value of Awards Granted Prior to year that were Forfeited or Modified during year | Dollar Value of Dividends or other Earnings Paid on Stock Awards prior to Vesting Date not otherwise included in Total Compensation | Total Adjustments to SCT Total Compensation | ||||||||||||||||||||
2024 | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
2023 | $ | $ | $ | $ | ($ | ($ | $ | $ | ($ | ||||||||||||||||||||
2022 | $ | $ | $ | $ | $ | ($ | $ | $ | ($ | ||||||||||||||||||||
2021 | $ | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||
(6) | The following table sets forth the adjustments made during each fiscal year presented in the Pay Versus Performance Table to arrive at compensation “actually paid” to our Prior PEO during fiscal years 2020 and 2021: |
Adjustments to Determine Compensation “Actually Paid” for Prior PEO | SCT Total Compensation4 | Deduction for Amounts Reported under the “Stock Awards” and “Option Awards” Column in the SCT | Increase for Fair Value of Awards Granted during the year that Remain Unvested as of Year End | Increase for Fair Value of Awards Granted during the year that Vest during year | Increase/ deduction for Change in Fair Value from prior Year-end to current Year-end of Awards Granted Prior to year that were Outstanding and Unvested as of Year-end | Increase/ deduction for Change in Fair Value from Prior Year-end to Vesting Date of Awards Granted Prior to year that Vested during year | Deduction of Fair Value of Awards Granted Prior to year that were Forfeited or Modified during year | Dollar Value of Dividends or other Earnings Paid on Stock Awards prior to Vesting Date not otherwise included in Total Compensation | Total Adjustments to SCT Total Compensation | ||||||||||||||||||||
2021 | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
2020 | $ | $ | $ | $ | ($ | ($ | $ | $ | ($ | ||||||||||||||||||||
(7) | The following table sets forth the adjustments made during each fiscal year presented in the Pay Versus Performance Table to arrive at the average compensation “actually paid” to our Non-PEO NEOs during each of the reportable years: |
Adjustments to Determine Compensation “Actually Paid” for Current PEO | SCT Total Compensation Of Average of Non-PEO NE | Deduction for Amounts Reported under the “Stock Awards” and “Option Awards” Column in the SCT | Increase for Fair Value of Awards Granted during the year that Remain Unvested as of Year End | Increase for Fair Value of Awards Granted during the year that Vest during year | Increase/ deduction for Change in Fair Value from prior Year-end to current Year-end of Awards Granted Prior to year that were Outstanding and Unvested as of Year-end | Increase/ deduction for Change in Fair Value from Prior Year-end to Vesting Date of Awards Granted Prior to year that Vested during year | Deduction of Fair Value of Awards Granted Prior to year that were Forfeited or Modified during year | Dollar Value of Dividends or other Earnings Paid on Stock Awards prior to Vesting Date not otherwise included in Total Compensation | Total Adjustments to SCT Total Compensation | ||||||||||||||||||||
2024 | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||
2023 | $ | $ | $ | $ | ($ | ($ | $ | $ | ($ | ||||||||||||||||||||
2022 | $ | $ | $ | $ | $ | ($ | $ | $ | ($ | ||||||||||||||||||||
2021 | $ | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||
2020 | $ | $ | $ | $ | ($ | ($ | $ | $ | ($ | ||||||||||||||||||||
(8) | Total shareholder return is calculated for each fiscal year based on a fixed investment of $100 from the day before the beginning of the earliest period reported in the table (December 30, 2020) through the end of each applicable year, assuming reinvestment of dividends. |
(9) | Horizons Marijuana Life Sciences Index is the peer group index selected by the Company for this purpose and for purposes of the Stock Performance Graph in our Annual Report. |
(10) | The dollar amounts reported represents the amount of net income (loss) reflected in the Company's audited financial statements for the applicable year or period. |
(11) | The Company has identified |
52 |
(12) | Represents Aphria Inc.’s Adjusted EBITDA for the year ended May 31, 2020, presented in USD and according to US GAAP. |
(13) | The “2024 EBITDA PSU Awards” as described in the Compensation Discussion & Analysis section are not included because there was |
53 |
Plan Category | (a) Number of securities to be issued upon exercise of outstanding options, warrants and rights | (b) Weighted average exercise price of outstanding options, warrants and rights(1) | (c) Number of securities remaining available for issuance under equity compensation plans (excluding securities reflected in column (a)) | ||||||||
Equity compensation plans approved by security holders | |||||||||||
Amended and Restated Tilray, Inc. 2018 equity Incentive Plan(2)(3) | 28,767,293 | $14.53 | 23,541,017 | ||||||||
Aphria Equity Incentive Plan | 678,405 | $7.56 | 0 | ||||||||
Privateer Holdings, Inc. 2011 Equity Incentive Plan | 49,166 | $3.46 | 0 | ||||||||
Equity compensation plans not approved by security holders | |||||||||||
Total | 29,494,864 | $13.44 | 23,541,017 | ||||||||
(1) | Excludes RSU awards because they have no exercise price. |
(2) | Consists of 26,307,972 shares of our common stock subject to RSU awards and options to purchase 3,231,999 shares of common stock. |
(3) | Our Amended and Restated 2018 Equity Incentive Plan includes provisions providing for an annual increase in the number of securities available for future issuance on the first day of each Fiscal Year 2024, equal to the least of: (a) 4% of the outstanding shares of capital stock as of the last day of the immediately preceding Fiscal Year 2024; and (b) such lesser amount as the Board may determine. |
55 |
56 |
Type of Fees(1) | 2023 | 2024 | ||||||
Audit Fees(2) | $1,125,111 | $1,477,595 | ||||||
Audit Related Fees(3) | 127,364 | 83,518 | ||||||
Tax Fees | — | — | ||||||
All other Fees | 112,380 | 148,000 | ||||||
Total | $1,364,855 | $1,709,113 | ||||||
(1) | The amounts shown are in USD. |
(2) | Audit fees are fees for professional services rendered in connection with the audit of our consolidated financial statements (including an assessment of our internal control over financial reporting) included in Item 8 of our Annual Reports filed on Form 10-K, reviews of our condensed consolidated financial statements included in our Quarterly Reports filed on Form 10-Q, statutory filings and registration statements. |
(3) | Audit-related fees are fees for services related to accounting consultation, compliance with regulatory requirements, and additional audit and audit-related fees for statutory audits and statutory reviews of non-consolidated controlled related entities. |
57 |
58 |
59 |
• | The directors designated as Class I directors have terms expiring at the 2025 annual meeting of stockholders; |
• | The directors designated as Class II directors have terms expiring at the 2026 annual meeting of stockholders; and |
• | The directors designated as Class III directors have terms expiring at the 2024 annual meeting of stockholders. |
Name | Current Position | Class | Term Expires | ||||||||
Jodi Butts | Nominating & Governance Committee Member; Independent Director | Class III | 2024 annual meeting of stockholders | ||||||||
David Clanachan | Audit Committee Member; Independent Director | Class II | 2026 annual meeting of stockholders | ||||||||
John M. Herhalt | Chair of the Audit Committee; Independent Director | Class I | 2025 annual meeting of stockholders | ||||||||
David Hopkinson | Nominating and Governance Committee & Compensation Committee Member; Independent Director | Class III | 2024 annual meeting of stockholders | ||||||||
Thomas Looney | Chair of the Compensation Committee and Audit Committee Member; Independent Director | Class III | 2024 annual meeting of stockholders | ||||||||
Renah Persofsky | Vice-Chair (Lead Director) and Chair of the Nominating and Governance Committee; Independent Director | Class II | 2026 annual meeting of stockholders | ||||||||
Irwin D. Simon | Chairman of the Board of Directors; President and Chief Executive Officer | Class II | 2026 annual meeting of stockholders | ||||||||
60 |
61 |
62 |
63 |
A-1 |
A. | The Company is authorized to issue two classes of stock to be designated, respectively, “Common Stock” and “Preferred Stock.” The total number of shares that the Company is authorized to issue is One Billion Two Hundred Eight Million_(1,208,000,000) One Billion Four Hundred Twenty-Six Million (1,426,000,000) shares of which One Billion One Hundred Ninety-Eight Million (1,198,000,000) One Billion Four Hundred Sixteen Million (1,416,000,000) shares shall be Common Stock (“Common Stock”), and Ten Million (10,000,000) shares of which shall be Preferred Stock (the “Preferred Stock”). The Preferred Stock shall have a par value of $0.0001 per share, and the Common Stock shall have a par value of $0.0001 per share. |
B. | The number of authorized shares of Common Stock or Preferred Stock may be increased or decreased (but not below the number of shares of Common Stock, or Preferred Stock then outstanding) by the affirmative vote of the holders of a majority of the voting power of all of the outstanding shares of stock of the Company entitled to vote thereon, without a vote of the holders of the Preferred Stock, or of any series thereof, or Common Stock unless a vote of any such holders is required pursuant to the terms of any certificate of designation filed with respect to any series of Preferred Stock (a “Certificate of Designation”). |
C. | The Preferred Stock authorized by this Amended and Restated Certificate of Incorporation may be issued from time to time in one or more series. The board of directors of the Company (the “Board of Directors”) is hereby expressly authorized to provide for the issue of all or any of the shares of the Preferred Stock in one or more series, and to fix the number of shares and to determine or alter for each such series, such voting powers, full or limited, or no voting powers, and such designation, preferences, and relative, participating, optional, or other rights and such qualifications, limitations, or restrictions thereof, as shall be stated and expressed in the resolution or resolutions adopted by the Board of Directors providing for the issuance of such shares and as may be permitted by the DGCL. The Board of Directors is also expressly authorized to increase or decrease the number of shares of any series subsequent to the issuance of shares of that series, but not below the number of shares of such series then outstanding. In case the number of shares of any series shall be decreased in accordance with the foregoing sentence, the shares constituting such decrease shall resume the status that they had prior to the adoption of the resolution originally fixing the number of shares of such series. |
A-2 |
D. | Except as provided above, the rights, preferences, privileges, restrictions and other matters relating to the Common Stock are as follows: |
1. | Definitions. For purposes of this Article IV(D), the following definitions shall apply: |
(a.) | “Change of Control Transaction” means (i) the sale, lease, exchange, or other disposition (other than liens and encumbrances created in the ordinary course of business, including liens or encumbrances to secure indebtedness for borrowed money that are approved by the Board of Directors, so long as no foreclosure occurs in respect of any such lien or encumbrance) of all or substantially all of the Company’s property and assets (which shall for such purpose include the property and assets of any direct or indirect subsidiary of the Company), provided that any sale, lease, exchange or other disposition of property or assets exclusively between or among the Company and any direct or indirect subsidiary or subsidiaries of the Company shall not be deemed a “Change of Control Transaction”; (ii) the merger, consolidation, business combination, or other similar transaction of the Company with any other entity, other than a merger, consolidation, business combination, or other similar transaction that would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) more than fifty percent (50%) of the total voting power represented by the voting securities of the Company and more than fifty percent (50%) of the total number of outstanding shares of the Company’s capital stock, in each case as outstanding immediately after such merger, consolidation, business combination, or other similar transaction, and the stockholders of the Company immediately prior to the merger, consolidation, business combination, or other similar transaction own voting securities of the Company, the surviving entity or its parent immediately following the merger, consolidation, business combination, or other similar transaction in substantially the same proportions (vis a vis each other) as such stockholders owned the voting securities of the Company immediately prior to the transaction; and (iii) the recapitalization, liquidation, dissolution, or other similar transaction involving the Company, other than a recapitalization, liquidation, dissolution, or other similar transaction that would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or being converted into voting securities of the surviving entity or its parent) more than fifty percent (50%) of the total voting power represented by the voting securities of the Company and more than fifty percent of the total number of outstanding shares of the Company’s capital stock, in each case as outstanding immediately after such recapitalization, liquidation, dissolution or other similar transaction, and the stockholders of the Company immediately prior to the recapitalization, liquidation, dissolution or other similar transaction own voting securities of the Company, the surviving entity or its parent immediately following the recapitalization, liquidation, dissolution or other similar transaction in substantially the same proportions (vis a vis each other) as such stockholders owned the voting securities of the Company immediately prior to the transaction. |
(b) | “Distribution” means (i) any dividend or distribution of cash, property or shares of the Company’s capital stock; and (ii) any distribution following or in connection with any liquidation, dissolution, or winding up of the Company, whether voluntary or involuntary. |
(c) | “IPO” means the Company’s first firmly underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933, as amended, covering the offer and sale of Common Stock for the account of the Company. |
2. | Rights relating to Distributions, Subdivisions, Combinations and Change of Control. |
(a) | Any Distributions paid or payable to the holders of shares of Common Stock shall be paid pro rata in accordance with the number of shares of Common Stock held by each such holder as of the record date of such Distribution; provided, however, that in the event a Distribution is paid |
A-3 |
(b) | In connection with any Change in Control Transaction, shares of Common Stock shall be treated equally, identically and ratably, on a per-share basis, with respect to any consideration into which such shares are converted or any consideration paid or otherwise distributed to stockholders of the Company. |
3. | Voting Rights. |
(a) | Common Stock. Each holder of shares of Common Stock shall be entitled to one (1) vote for each share thereof held. |
(b) | General. Except as otherwise expressly provided herein or as required by law, the holders of Preferred Stock and Common Stock shall vote together and not as separate series or classes. |
A. | The liability of the directors of the Company for monetary damages shall be eliminated to the fullest extent under applicable law. |
B. | To the fullest extent permitted by applicable law, the Company is authorized to provide indemnification of (and advancement of expenses to) directors, officers and agents of the Company (and any other persons to which applicable law permits the Company to provide indemnification) through Bylaw provisions, agreements with such agents or other persons, vote of stockholders or disinterested directors or otherwise in excess of the indemnification and advancement otherwise permitted by Section 145 of the DGCL and, if applicable, Section 317 of the California General Corporation Law. If the DGCL or any other law of the State of Delaware is amended after approval by the stockholders of this Article V to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability of a director to the Company shall be eliminated or limited to the fullest extent permitted by the DGCL as so amended. |
C. | Any repeal or modification of this Article V shall only be prospective and shall not affect the rights or protections or increase the liability of any director under this Article V in effect at the time of the alleged occurrence of any action or omission to act giving rise to liability or indemnification. |
D. | Unless the Company consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall be the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of the Company; (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee of the Company to the Company or the Company’s stockholders; (iii) any action asserting a claim against the Company arising pursuant to any provision of the DGCL, the certificate of incorporation or the Bylaws of the Company; or (iv) any action asserting a claim against the Company governed by the internal affairs doctrine. Unless the Company consents in writing to the selection of an alternative forum, the federal district courts of the United States of America shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act of 1933. Any person or entity purchasing or otherwise acquiring any interest in shares of capital stock of the Company shall be deemed to have notice of and to have consented to the provisions of this Section D of Article V. |
A-4 |
1. | Generally. The management of the business and the conduct of the affairs of the Company shall be vested in its Board of Directors. The number of directors that shall constitute the Board of Directors shall be fixed exclusively by resolutions adopted by a majority of the authorized number of directors constituting the Board of Directors. |
2. | Election. |
(a) | Subject to the rights of the holders of any series of Preferred Stock to elect additional directors under specified circumstances, following the closing of the IPO, and for so long as permitted by applicable law, the directors shall be divided into three classes designated as Class I, Class II and Class III, respectively. The Board of Directors is authorized to assign members of the Board of Directors already in office to such classes at the time the classification becomes effective. At the first annual meeting of stockholders following the closing of the IPO, the term of office of the Class I directors shall expire and Class I directors shall be elected for a full term of three years. At the second annual meeting of stockholders following the IPO, the term of office of the Class II directors shall expire and Class II directors shall be elected for a full term of three years. At the third annual meeting of stockholders following the IPO, the term of office of the Class III directors shall expire and Class III directors shall be elected for a full term of three years. At each succeeding annual meeting of stockholders, directors shall be elected for a full term of three years to succeed the directors of the class whose terms expire at such annual meeting. |
(b) | No stockholder entitled to vote at an election for directors may cumulate votes to which such stockholder is entitled unless required by applicable law at the time of such election. During such time or times that applicable law requires cumulative voting, every stockholder entitled to vote at an election for directors may cumulate such stockholder’s votes and give one candidate a number of votes equal to the number of directors to be elected multiplied by the number of votes to which such stockholder’s shares are otherwise entitled, or distribute the stockholder’s votes on the same principle among as many candidates as such stockholder thinks fit. No stockholder, however, shall be entitled to so cumulate such stockholder’s votes unless (i) the names of such candidate or candidates have been placed in nomination prior to the voting and (ii) the stockholder has given notice at the meeting, prior to the voting, of such stockholder’s intention to cumulate such stockholder’s votes. If any stockholder has given proper notice to cumulate votes, all stockholders may cumulate their votes for any candidates who have been properly placed in nomination. Under cumulative voting, the candidates receiving the highest number of votes, up to the number of directors to be elected, are elected. |
(c) | Notwithstanding the foregoing provisions of this section, each director shall serve until his or her successor is duly elected and qualified or until his earlier death, resignation or removal. No decrease in the number of directors constituting the Board of Directors shall shorten the term of any incumbent director. |
3. | Removal of Directors. Subject to any limitations imposed by applicable law and subject to the rights of the holders of any series of Preferred Stock, any individual director or directors may be |
A-5 |
4. | Vacancies. Subject to any limitations imposed by applicable law and subject to the rights of the holders of any series of Preferred Stock, any vacancies on the Board of Directors resulting from death, resignation, disqualification, removal or other causes and any newly created directorships resulting from any increase in the number of directors, shall, unless the Board of Directors determines by resolution that any such vacancies or newly created directorships shall be filled by the stockholders and except as otherwise provided by applicable law, be filled only by the affirmative vote of a majority of the directors then in office, even though less than a quorum of the Board of Directors, and not by the stockholders. Any director elected in accordance with the preceding sentence shall hold office for the remainder of the full term of the director for which the vacancy was created or occurred and until such director’s successor shall have been elected and qualified or until his earlier death, resignation or removal. |
B. | Stockholder Actions. No action shall be taken by the stockholders of the Company except at an annual or special meeting of stockholders called in accordance with the Bylaws, and action shall be taken by the stockholders by written consent or electronic transmission. Advance notice of stockholder nominations for the election of directors and of business to be brought by stockholders before any meeting of the stockholders of the Company shall be given in the manner provided in the Bylaws of the Company and subject to applicable law. |
C. | Bylaws. The Board of Directors is expressly empowered to adopt, amend or repeal the Bylaws of the Company. Any adoption, amendment or repeal of the Bylaws of the Company by the Board of Directors shall require the approval of a majority of the authorized number of directors. The stockholders shall also have power to adopt, amend or repeal the Bylaws of the Company; provided, however, that, in addition to any vote of the holders of any class or series of stock of the Company required by law or by this Amended and Restated Certificate of Incorporation, such action by stockholders shall require the affirmative vote of the holders of at least 66 2/3% of the voting power of all of the then-outstanding shares of the capital stock of the Company entitled to vote generally in the election of directors, voting together as a single class. |
A. | The Company renounces any interest or expectancy of the Company or any of its Affiliated Companies in, or in being offered an opportunity to participate in, any Dual Opportunity about which a Dual Role Person acquires knowledge. A Dual Role Person shall have no duty to communicate or offer to the Company or any of its Affiliated Companies any Dual Opportunity that such Dual Role Person has communicated or offered to the Investment Fund, shall not be prohibited from communicating or offering any Dual Opportunity to the Investment Fund, and shall not be liable to the Company or its stockholders for breach of any fiduciary duty as a stockholder, director or officer of the Company, as the case may be, resulting from (i) the failure to communicate or offer to the Company or any of its Affiliated Companies any Dual Opportunity that such Dual Role Person has communicated or offered to the Investment Fund or (ii) the communication or offer to the Investment Fund of any Dual Opportunity, so long as (x) the Dual Opportunity does not become known to the Dual Role Person expressly and solely in his or her capacity as a director or officer of the Company, and (y) the Dual Opportunity is not presented by the Dual Role Person to any party other than the Investment Fund and the Dual Role Person does not pursue the Dual Opportunity individually. |
B. | In addition to and notwithstanding the foregoing provisions of this Article VII, the Company renounces any interest or expectancy of the Company or any of its Affiliated Companies in, or in being offered an opportunity to participate in, any business opportunity that the Company is not financially able or |
A-6 |
C. | For purposes of this Article VII: |
D. | The provisions of this Article VII shall have no further force or effect with respect to the Investment Fund at such time as (i) the Company and the Investment Fund are no longer Affiliates and (ii) none of the directors and/or officers and/or general partners of the Investment Fund serve as directors and/or officers of the Company and its Affiliated Companies; provided, however, that any such termination shall not terminate the effect of the provisions of this Article VII with respect to any agreement, arrangement or other understanding between the Company or an Affiliated Company thereof, on the one hand, and the Investment Fund, on the other hand, that was entered into before such time or any transaction entered into in the performance of such agreement, arrangement or other understanding, whether entered into before or after such time. |
E. | Any person or entity purchasing or otherwise acquiring or obtaining any interest in any capital stock of the Company shall be deemed to have notice and to have consented to the provisions of this Article VII. |
F. | The invalidity or unenforceability of any particular provision, or part of any provision, of this Article VII shall not affect the other provisions or parts hereof, and this Article VII shall be construed in all respects as if such invalid or unenforceable provisions or parts were omitted. |
A-7 |
A. | The Company reserves the right to amend, alter, change or repeal any provision contained in this Restated Certificate, in the manner now or hereafter prescribed by statute, except as provided in Section B of this Article VIII, and all rights conferred upon the stockholders herein are granted subject to this reservation. |
B. | Notwithstanding any other provisions of this Restated Certificate or any provision of law that might otherwise permit a lesser vote or no vote, but in addition to any affirmative vote of the holders of any particular class or series of the Company required by law or by this Restated Certificate or any Certificate of Designation, the affirmative vote of either (a) the holders of a majority of the voting power of all then-outstanding shares of capital stock entitled to vote generally at an election of directors, voting together as a single class or (b) the holders of at least 66 2/3% of the voting power of all of the then outstanding shares of capital stock of the Company entitled to vote generally in the election of directors, voting together as a single class, shall be required to alter, amend or repeal Articles V, VI, and VIII. |
A-8 |